Jazz Pharmaceuticals to attend Jefferies Virtual Healthcare conference on June 2, 2021
DUBLIN, May 26, 2021 / PRNewswire / – Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that its leadership team will provide company insight and business and financial updates at the Jefferies Virtual Healthcare Conference on Wednesday, June 2, 2021, at 1 p.m. ET / 6:00 p.m. IST.
Interested parties can access the live webcast through the Investors section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com. A replay of the webcast will be archived on the website for at least one week.
About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharmaceutical company dedicated to innovating to transform the lives of patients and their families. We are committed to developing drugs that change the lives of people with serious illnesses – often with limited or no treatment options. We have a diverse portfolio of commercialized drugs and new product candidates, from early to late stage development, in neuroscience and oncology. We are actively exploring new options for patients, including new compounds, small molecules and biologics, as well as through cannabinoid science and innovative delivery technologies. Jazz is headquartered in Dublin, Ireland, and has employees around the world, serving patients in nearly 75 countries. For more information, please visit www.jazzpharmaceuticals.com and follow @JazzPharma on Twitter.
Andrea N. Flynn, Ph.D.
Vice-President, Head, Investor Relations
Ireland +353 1 634 7887
Vice-President, Corporate Affairs and Government Relations
Ireland +353 1 697 2141
United States +1 215 867 4910
SOURCE Jazz Pharmaceuticals plc